COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02756858
Recruitment Status : Active, not recruiting
First Posted : April 29, 2016
Last Update Posted : November 19, 2019
Information provided by (Responsible Party):
Anavex Life Sciences Corp.